We will revolutionize Cancer Treatment
Our Mission
Precision AI Solutions is dedicated making precision cancer treatment readily available to all from community clinics to world-renowned hospitals.
Our Purpose
Driven by the desire to make a meaningful impact, our purpose is to empower oncologists and healthcare providers with accurate, data-driven insights. We strive to transform the landscape of cancer care by delivering tailored treatment solutions based on individual gene expression profiles.
Sophia's Story
Turning personal tragedy into a mission to save lives
Sophia's journey began with a profound personal tragedy that shaped the course of her life and ignited a passion for transforming cancer treatment. A decade ago, she lost her father to colon cancer. The experience left an indelible mark on her soul and planted the seed for her future aspirations.
After earning her doctorate in bioengineering, Sophia continued her quest at the renowned Moffitt Cancer Center as a postdoctoral researcher. Here, she delved deeper into the intricate relationships between genetics, cancer, and medication.
In 2022, Sophia's vision began to materialize. Alongside a like-minded partner who shared her passion and commitment, she founded Precision AI Solutions. Their mission was clear: to revolutionize cancer treatment using the latest advancements in artificial intelligence and gene sequencing.
Our Team
We are a team of innovative thinkers who work together to create life-transforming precision medicine democratized for everyone.
Edwin brings decades of experience in AI and machine learning, with a proven track record across leadership, strategy, marketing, finance, and engineering. As a seasoned entrepreneur, he has built companies and product lines from the ground up—successfully attracting top talent, raising capital, and driving execution with focus and discipline.
The best time to plant a tree was 20 years ago. The second best time is now
Sophia has extensive experience in cancer biology and pharmacogenomics. She creatively helps you with sample testing, data analysis and solution support. She is excellent in solving problems and proposing solutions in a data driven strategy.
The man who moves a mountain begins by carrying away small stones.
Zheng has more than a decade of experience building customer-centric, impactful products at early startups in healthcare, education, and gaming. He enjoys identifying and solving complex customer needs.
Have no fear of perfection, you'll never reach it. - Salvador Dalí
Seth has a decade of comprehensive experience in software development spanning from infrastructure to development. A background in biometric systems development offers expertise in combining software control with physical hardware of all kinds.
The challenge of the unknown future is so much more exciting than the stories of the accomplished past. - Simon Sinek
Our board of Advisors
Cancer isn't a one-size-fits-all disease, and neither are our advisors. We are grateful to have a diverse group of experts in oncology, cancer biology, and AI who provide us with invaluable insights and guidance as we work towards our mission of revolutionizing cancer treatment.
Andrew Ko | MD
Chief Medical Officer
UCSF Pancreas Center
Dae Won Kim | MD
Research Scientist, Tumor Biology
Moffitt Cancer Center
Eileen O'Rielly | MD
Medical Oncology Chair
Memorial Sloan Kettering Cancer Center
Eric Lau | MD PhD
Research Scientist, Tumor Biology
Moffitt Cancer Center
Jennifer Valerin | MD PhD
Clinical Professor of Medicine
UC Irvine, School of Medicine
Marc Shuman | MD
Emeritus Chief Oncologist (Hematology)
UCSF Cancer Center
Mark Lu | MD PhD
Professor & Vice Chair
UCSF Dept. of Lab Medicine
Shian-Jiun (SJ) Shih | MD
CEO & Co-Founder of Cellentia
Cellentia: San Francisco
Mark Tucker | PhD
Quality & Regulatory Consultant FDA
Formerly FDA & Genentech